Product Description
Impedance Cardiography by PhysioFlow for Non-invasive Cardiac Output Monitoring (Sourced from: https://clinicaltrials.gov/ct2/show/NCT02873494)
Mechanisms of Action: PDE2 Inhibitor
Novel Mechanism: Yes
Modality: Device
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: University Hospital, Lille
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| PF-ECHO | N/A |
Completed |
Cardiac Output, Low|Stroke |
2016-02-01 |
2019-03-20 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|